Sign in

CIK 0001761612

  • Non-accelerated filer
  • Smaller reporting company

BICYCLE THERAPEUTICS PLC

Sign in to watch
Ticker
BCYC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 1223261503
Business address
BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
Former names
BICYCLE THERAPEUTICS Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$64,039
in 7 filings, $7K under 10b5-1 plans

Net −$64,039. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-07-14 BINGHAM KATE Director Sale −43,378 $34.01 $1.5M 1,831,671
2021-07-14 BINGHAM KATE Director Sale −917 $34.01 $31K 38,708
2021-07-14 BINGHAM KATE Director Sale −43,378 $34.01 $1.5M 1,831,671
2021-07-14 BINGHAM KATE Director Sale −917 $34.01 $31K 38,708
2021-07-13 BINGHAM KATE Director Sale −588 $33.50 $20K 1,875,049
2021-07-13 BINGHAM KATE Director Sale −12 $33.50 $402 39,625
2021-07-13 BINGHAM KATE Director Sale −588 $33.50 $20K 1,875,049
2021-07-13 BINGHAM KATE Director Sale −12 $33.50 $402 39,625
2021-01-04 BINGHAM KATE Director Grant or award · Stock Option (right to buy) +19,000 19,000
2020-01-02 BINGHAM KATE Director Grant or award · Stock Option (right to buy) +16,000 16,000
2019-05-28 BINGHAM KATE Director Conversion +874,709 874,709
2019-05-28 BINGHAM KATE Director Conversion +623,196 1,497,905
2019-05-28 BINGHAM KATE Director Conversion +18,485 18,485
2019-05-28 BINGHAM KATE Director Conversion +13,169 31,654
2019-05-28 BINGHAM KATE Director Purchase +377,732 $14.00 $5.3M 1,875,637
2019-05-28 BINGHAM KATE Director Purchase +7,983 $14.00 $112K 39,637
2019-05-28 BINGHAM KATE Director Conversion · Series A Preferred Shares −874,709 0
2019-05-28 BINGHAM KATE Director Conversion · Series B1 Preferred Shares −623,196 0
2019-05-28 BINGHAM KATE Director Conversion · Series A Preferred Shares −18,485 0
2019-05-28 BINGHAM KATE Director Conversion · Series B1 Preferred Shares −13,169 0

Page 1 of 1 · 20 trades